Sign in

CIK 0000899460

  • Large accelerated filer

MANNKIND CORP

Sign in to watch
Ticker
MNKD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
133607736
Phone
+1 818-661-5000
Business address
1 CASPER STREET, DANBURY, CT, 06810
  1. 4 Grant or award Chief Executive Officer acquired 60,403 shares (grant or award)
  2. 4 Grant or award Director acquired 32,608 shares (grant or award)
  3. 3 Insider Initial Statement of Ownership
  4. 5 Insider Annual Insider Trading Report
  5. 4 Open-market buy Chief Financial Officer bought 1,860 shares at $1.07 ($1,990)
  6. 4 Open-market buy Corp VP, Chief People Officer bought 5,000 shares at $1.07 ($5,350)
  7. 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $1.07 ($5,350)
  8. 4 Open-market buy Chief Medical Officer bought 5,000 shares at $1.07 ($5,350)
  9. 4 Open-market buy Chief Marketing Officer bought 5,000 shares at $1.07 ($5,350)
  10. 4 Open-market buy Chief Compliance Officer bought 5,000 shares at $1.07 ($5,350)
  11. 4 Open-market buy Chief Executive Officer bought 5,000 shares at $1.07 ($5,350)
  12. 4 Grant or award Chief Medical Officer acquired 2,824 shares (grant or award)
  13. 4 Grant or award Corp VP, Chief People Officer acquired 14,124 shares (grant or award)
  14. 4 Grant or award Chief Commercial Officer acquired 14,124 shares (grant or award)
  15. 4 Grant or award Chief Executive Officer acquired 25,000 shares (grant or award)
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Open-market buy Corp VP, Chief People Officer bought 5,000 shares at $1.31 ($6,550)
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Chief Commercial Officer bought 5,000 shares at $1.31 ($6,550)

Page 19 of 50 · 999 filings